RemSleep Holdings (RMSL) Total Debt Growth (1y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -5.48% |
| 10 | RemSleep Holdings | - | - | -7,636.00 | 217.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 217.55% |
| Jun 30, 2025 | 10.84% |
| Mar 31, 2025 | -8.65% |
| Dec 31, 2024 | -90.83% |
| Mar 31, 2024 | 154.15% |
| Dec 31, 2023 | -2.58% |
| Mar 31, 2023 | 75.98% |
| Dec 31, 2022 | -45.21% |
| Jun 30, 2022 | -10.40% |
| Mar 31, 2022 | -90.07% |
| Dec 31, 2021 | 44.45% |
| Sep 30, 2021 | -79.23% |
| Jun 30, 2021 | -14.57% |
| Mar 31, 2021 | 92.92% |
| Dec 31, 2020 | -1.42% |
| Sep 30, 2020 | -1.39% |
| Jun 30, 2020 | -1.37% |
| Mar 31, 2020 | -1.34% |
| Dec 31, 2019 | -34.22% |
| Sep 30, 2019 | 5.51% |
| Jun 30, 2019 | 32.46% |
| Mar 31, 2019 | 376.26% |
| Dec 31, 2018 | 54.35% |
| Sep 30, 2018 | 37.20% |
| Jun 30, 2018 | 24.66% |
| Dec 31, 2017 | 71.63% |
| Dec 31, 2016 | 55.11% |
| Dec 31, 2015 | -89.62% |
| Dec 31, 2014 | -44.16% |
| Sep 30, 2014 | -55.25% |
| Jun 30, 2014 | 0.00% |
| Mar 31, 2014 | 4,772.50% |
| Dec 31, 2013 | 4,914.27% |
| Sep 30, 2013 | 6,157.52% |
| Jun 30, 2013 | -27.06% |
| Mar 31, 2013 | 103.79% |
| Sep 30, 2012 | -21.99% |